Actively Recruiting
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-07-15
120
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
Z
Zhejiang University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Crohn's disease (CD) is a chronic, nonspecific inflammatory disease that can affect the entire digestive tract. It is difficult to cure and often relapses, causing long-term suffering for patients. This persistent condition significantly impacts their mental and psychological well-being, leading to a noticeable decline in their quality of life. Furthermore, these negative emotions can contribute to disease recurrence and the worsening of symptoms. Positive psychological intervention (PPI) refers to the enhancement of positive emotions, cognition, and behaviors to increase well-being and alleviate symptoms. Therefore, this study aims to use psychological methods to help CD patients better recognize and understand their positive experiences, thus aiding them in coping with stress and adversity more effectively.
CONDITIONS
Official Title
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Crohn's disease according to 2018 Chinese Medical Association criteria
- Aged between 18 and 75 years
- Mild to moderate anxiety (GAD-7 score 5-14) or mild to moderate depression (PHQ-9 score 5-14)
- Understands and agrees to study requirements and has signed informed consent
- Able to read, access the internet, and use WeChat or mobile apps independently or with family help
- Able to complete all course training and follow-ups
You will not qualify if you...
- History or current diagnosis of psychiatric illness or cognitive impairment, or currently taking psychiatric medications
- Working in psychology or having studied positive psychology
- Having other intestinal diseases or cancer
- Severe primary diseases of the heart, brain, liver, or kidneys
- Withdrawal due to loss to follow-up, severe complications, or significant condition changes preventing study continuation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here